Patents by Inventor Christoph Parthier

Christoph Parthier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8859250
    Abstract: Novel crystal structures of human and murine glutaminyl cyclase (QC, EC 2.3.2.5), methods of preparing the crystals, as well as the use of said crystal structures for identifying inhibitors of human and murine glutaminyl cyclase.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: October 14, 2014
    Assignee: Probiodrug AG
    Inventors: Stephan Schilling, Jens-Ulrich Rahfeld, Birgit Koch, Michael Wermann, Christoph Parthier, David Ruiz-Carillo, Milton T. Stubbs
  • Patent number: 8741614
    Abstract: A crystal comprising human isoglutaminyl cyclase having a characterized space group of P1211 and unit cell dimensions of +/?5% of a=126.51 ?, b=109.68 ?, c=159.53 ?, ?=90.0°, ?=104.9° and ?=90.0°.
    Type: Grant
    Filed: October 28, 2011
    Date of Patent: June 3, 2014
    Assignee: Probiodrug AG
    Inventors: Anett Stephan, Stephan Schilling, Jens-Ulrich Rahfeld, Michael Wermann, Christoph Parthier, Hans-Ulrich Demuth, David Ruiz-Carillo, Milton T. Stubbs
  • Patent number: 8409837
    Abstract: A novel crystal structures of human and murine glutaminyl cyclase (QC, EC 2.3.2.5), methods of preparing the crystals, as well as the use of said crystal structures for identifying inhibitors of human and murine glutaminyl cyclase.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: April 2, 2013
    Assignee: Probiodrug AG
    Inventors: Stephan Schilling, Jens-Ulrich Rahfeld, Birgit Koch, Michael Wermann, Christoph Parthier, David Ruiz-Carillo, Milton T. Stubbs
  • Publication number: 20120108449
    Abstract: A crystal comprising human isoglutaminyl cyclase having a characterised space group of P1211 and unit cell dimensions of +/?5% of a=126.51 ?, b=109.68 ?, c=159.53 ?, ?=90.0°, ?=104.9° and ?=90.0°.
    Type: Application
    Filed: October 28, 2011
    Publication date: May 3, 2012
    Applicant: PROBIODRUG AG
    Inventors: Anett Stephan, Stephan Schilling, Jens-Ulrich Rahfeld, Michael Wermann, Christoph Parthier, Hans-Ulrich Demuth, David Ruiz-Carillo, Milton T. Stubbs
  • Publication number: 20120045815
    Abstract: A novel crystal structures of human and murine glutaminyl cyclase (QC, EC 2.3.2.5), methods of preparing the crystals, as well as the use of said crystal structures for identifying inhibitors of human and murine glutaminyl cyclase.
    Type: Application
    Filed: August 19, 2011
    Publication date: February 23, 2012
    Applicant: PROBIODRUG AG
    Inventors: Stephan Schilling, Jens-Ulrich Rahfeld, Birgit Koch, Michael Wermann, Christoph Parthier, David Ruiz-Carillo, Milton T. Stubbs
  • Patent number: 7807782
    Abstract: The invention relates to a method for linking two or more molecular substances, by means of adapter segments, which bring about a targeted interaction based upon the affinity of proline-rich amino acid sequences and protein domains of the type WW.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: October 5, 2010
    Assignee: ACGT ProGenomics
    Inventors: Gerald Boehm, Ulrich Schmidt, Christoph Parthier, Constanze Guenther
  • Publication number: 20060252130
    Abstract: The invention relates to a method for linking two or more molecular substances, by means of adapter segments, which bring about a targeted interaction based upon the affinity of proline-rich amino acid sequences and protein domains of the type WW.
    Type: Application
    Filed: June 1, 2006
    Publication date: November 9, 2006
    Applicant: ACGT PreGenomics AG
    Inventors: Gerald Boehm, Ulrich Schmidt, Christoph Parthier, Constanze Gunther